Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Mutated NPM1 As Target for Immunotherapy of Acute Myeloid Leukemia

Dyantha I. Van Der Lee, BSc., Helena M. Bijen, MSc, Renate S. Hagedoorn, ing., Willy M. Honders, ing., Michel G.D. Kester, ing., Dirk M. van der Steen, ing., Arnoud H. de Ru, ing., Inge Jedema, PhD, Hendrik Veelken, MD PhD, Mirjam H.M. Heemskerk, PhD, Peter A. van Veelen, PhD, J.H. Frederik Falkenburg, MD PhD, Marieke Griffioen, PhD

Blood (2017) 130 (Supplement 1): 168.

https://doi.org/10.1182/blood.V130.Suppl_1.168.168

Published: 2017

Journal Articles

Induction of Antigen-Specific T-Cell Responses through Dendritic Cell Vaccination in AML: Results of a Phase I/II Trial and Ex Vivo Enhancement By Checkpoint Blockade

Felix S. Lichtenegger, MD, Katrin Deiser, PhD, Maurine Rothe, Frauke M. Schnorfeil, PhD, Christina Krupka, PhD, Christian Augsberger, Thomas Köhnke, MD, Veit L. Bücklein, MD, Torben Altmann, MD, Andreas Moosmann, Monika Brüggemann, MD PhD, Mirjam H.M. Heemskerk, PhD, Georg Wittmann, MD, Beate Wagner, MD, Wolfgang Hiddemann, MD, Iris Bigalke, PhD, Gunnar Kvalheim, MD PhD, Marion Subklewe, MD

Blood (2016) 128 (22): 764.

https://doi.org/10.1182/blood.V128.22.764.764

Published: 2016

Journal Articles

Inducible MyD88/CD40 (iMC) Enhances Proliferation and Survival of Tumor-Specific TCR-Modified T Cells and Improves Anti-Tumor Efficacy in Myeloma

Tsvetelina Pentcheva-Hoang, PhD, David Torres, Tania Rodriguez, PhD, Ana Korngold, PhD, An Lu, Jeannette Crisostomo, Annemarie Moseley, MD PhD, Lorenz Jahn, Mirjam H.M. Heemskerk, PhD, Kevin M Slawin, MD, David M Spencer, PhD, Aaron E Foster, PhD

Blood (2016) 128 (22): 4550.

https://doi.org/10.1182/blood.V128.22.4550.4550

Published: 2016

Journal Articles

Endogenous Immunoglobulin-Derived Neoepitopes Are Processed and Form a Sizeable Fraction of the HLA Class I Ligandome of Human Lymphoma Cells

Cornelis A.M. van Bergen, PhD, Dirk M. van der Steen, Michel G.D. Kester, Marvyn T. Koning, BSc, Peter A. van Veelen, PhD, Marieke Griffioen, PhD, J.H. Frederik Falkenburg, MD PhD, Mirjam H.M. Heemskerk, PhD, Hendrik Veelken, MD PhD, Marcelo A Navarrete, MD PhD

Blood (2016) 128 (22): 914.

https://doi.org/10.1182/blood.V128.22.914.914

Published: 2016

Journal Articles

T Cell Receptor Gene Therapy Targeting the Intracellular Transcription Factor Bob1 for the Treatment of Multiple Myeloma and Other B Cell Malignancies

Lorenz Jahn, Renate S. Hagedoorn, Pleun Hombrink, PhD, Michel G.D. Kester, Dirk M. van der Steen, Chopie Hassan, Marjolein P. Schoonakker, Erwin van der Pijl, Peter A. van Veelen, PhD, J.H. Frederik Falkenburg, MD PhD, Mirjam H.M. Heemskerk, PhD

Blood (2015) 126 (23): 3002.

https://doi.org/10.1182/blood.V126.23.3002.3002

Published: 2015

Journal Articles

Inducible MyD88/CD40 Enhances Proliferation and Survival of PRAME-Specific TCR-Engineered T Cells and Increases Anti-Tumor Effects in Myeloma

Tsvetalina Hoang, PhD, Aaron Foster, PhD, Jeannette Crisostomo, An Lu, Annemarie Moseley, MDPhD, Mirjam H.M. Heemskerk, PhD, Kevin M Slawin, MD, David M Spencer, PhD

Blood (2015) 126 (23): 1886.

https://doi.org/10.1182/blood.V126.23.1886.1886

Published: 2015

Journal Articles

Functional Evaluation of T-Cells Generated from WT1-TCR Transduced Human Hematopoietic Stem Cells Using the OP9-DL1 Coculture System

Sarah Bonte, Master in Biomedical MDcine, Sylvia Snauwaert, MD PhD, Jasper Van Heuverswyn, Glenn Goetgeluk, Mirjam H.M. Heemskerk, PhD, Hans Stauss, MD PhD, Renata Stripecke, PhD, Bart Vandekerckhove, MD PhD, Tessa Kerre, MD PhD

Blood (2014) 124 (21): 2152.

https://doi.org/10.1182/blood.V124.21.2152.2152

Published: 2014

Journal Articles

T Cell Receptors Specific for the Intracellular Transcription Factor Bob1 Allow Efficient Targeting of Human B Cell Leukemia and Multiple Myeloma

Lorenz Jahn, Pleun Hombrink, Michel G.D. Kester, Dirk M. van der Steen, Renate S. Hagedoorn, Chopie Hassan, Marjolein P. Schoonakker, Erwin van der Pijl, Peter A. van Veelen, PhD, J.H. Frederik Falkenburg, MD PhD, Mirjam H.M. Heemskerk, PhD

Blood (2014) 124 (21): 3832.

https://doi.org/10.1182/blood.V124.21.3832.3832

Published: 2014

Journal Articles

High-Affinity CD20-Specific T-Cell Receptors Suitable for Adoptive Immunotherapy in the Treatment of CD20 low B-Cell Malignancies

Lorenz Jahn, Pleun Hombrink, Chopie Hassan, Michel G.D. Kester, Renate S. Hagedoorn, Dirk M. van der Steen, Marjolein P. Schoonakker, J.H. Frederik Falkenburg, MD PhD, Peter A. van Veelen, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2014) 124 (21): 3837.

https://doi.org/10.1182/blood.V124.21.3837.3837

Published: 2014

Journal Articles

Imprint Of Early CMV Reactivation On The Reconstituting T-Lymphocyte Compartment One and Two Year After Hematopoietic Stem Cell Transplantation

Gertjan Lugthart, MD, Monique M. van Ostaijen-Ten Dam, Cornelia M. Jol-van der Zijde, Tessa C. van Holten, Michel G.D. Kester, Mirjam H.M. Heemskerk, PhD, Robbert G.M. Bredius, MD, PhD, Maarten J.D. van Tol, PhD, Arjan C. Lankester, MD, PhD

Blood (2013) 122 (21): 3295.

https://doi.org/10.1182/blood.V122.21.3295.3295

Published: 2013

Journal Articles

Occurrence of T Cells Specific for the Aspergillus Proteins Crf1 and Catalase1 in Patients Recovering From Invasive Aspergillosis

Hetty Jolink, MD, Jaap T van Dissel, MD, PhD, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk, PhD

Blood (2011) 118 (21): 3008.

https://doi.org/10.1182/blood.V118.21.3008.3008

Published: 2011

Journal Articles

HLA-Peptidomics and the Identification of Clinical Relevant Minor Histocompatibility Antigens,

Pleun Hombrink, MSc, Chopie Hassan, Michel G.D. Kester, Cornelis A.M. van Bergen, J.H.F. Falkenburg, MD, PhD, Peter A. van Veelen, Mirjam H.M. Heemskerk, PhD

Blood (2011) 118 (21): 4038.

https://doi.org/10.1182/blood.V118.21.4038.4038

Published: 2011

Journal Articles

Identification of Multiple HLA Class II Epitopes of Aspergillus Fumigatus by Generation of CD4+ T Cell Clones Recognizing the A. Fumigatus proteins Crf1 and Catalase1

Hetty Jolink, MD, Els van Oorschot, Ed J Kuijper, MD, PhD, Jan Willem Drijfhout, PhD, Jaap T van Dissel, MD, PhD, J.H.Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2010) 116 (21): 2332.

https://doi.org/10.1182/blood.V116.21.2332.2332

Published: 2010

Journal Articles

Extracellular Domains of CD8a and β Subunits Are Required and Sufficient for HLA Class I Restricted Helper Activity of TCR-Engineered CD4 + T Cells.

Marleen M van Loenen, MSc, Renate S. Hagedoorn, MSc, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2009) 114 (22): 3574.

https://doi.org/10.1182/blood.V114.22.3574.3574

Published: 2009

Journal Articles

Allogeneic HLA-A2-Restricted WT1-Specific T Cells From Mismatched Donors Are Highly Reactive but Show Potentially Hazardous Promiscuity.

Willem J.J. Falkenburg, J. Joseph Melenhorst, PhD, Michel G.D. Kester, Pleun Hombrink, Mirjam H.M. Heemskerk, PhD, Emma Gostick, David A. Price, J.H. Frederik Falkenburg, MD, PhD, A.John Barrett, MD, PhD, Inge Jedema, PhD

Blood (2009) 114 (22): 4081.

https://doi.org/10.1182/blood.V114.22.4081.4081

Published: 2009

Journal Articles

High Avidity PRAME Specific T Cells Derived From In Vivo HLA Mismatched Transplantation Setting Potentially Useful for Immunotherapeutic Strategies.

Avital L. Amir, MD, Dirk M. van der Steen, Renate S. Hagedoorn, Marieke Griffioen, PhD, J.H. Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2009) 114 (22): 4087.

https://doi.org/10.1182/blood.V114.22.4087.4087

Published: 2009

Journal Articles

Optimization of the HA-1-Specific T Cell Receptor for Gene Therapy of Hematological Malignancies.

Marleen M van Loenen, MSc, Renate S. Hagedoorn, MSc, Renate de Boer, BSc, Esther M. van Egmond, BSc, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2009) 114 (22): 4093.

https://doi.org/10.1182/blood.V114.22.4093.4093

Published: 2009

Journal Articles

SNP-Based Genome-Wide Identification of Hematopoiesis-Restricted Minor Histocompatibility Antigens

Pleun Hombrink, MSc, Sine R Hadrup, PhD, Arne Bakker, PhD, J.H. Frederik Falkenburg, MD, PhD, Peter A. Von Dem Borne, MD, PhD, Ton N Schumacher, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2008) 112 (11): 814.

https://doi.org/10.1182/blood.V112.11.814.814

Published: 2008

Journal Articles

Recombination of Endogenous TCR Chains with Retrovirally Introduced TCR Chains Can Result in Mixed T Cell Receptor Dimers Harbouring Harmful Alloreactivity

Marleen M Van Loenen, MSc, Renate de Boer, BSc, Gerdien L Volbeda, BSc, Avital L Amir, MD, Renate S. Hagedoorn, MSc, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2008) 112 (11): 823.

https://doi.org/10.1182/blood.V112.11.823.823

Published: 2008

Journal Articles

Alloreactivity of Virus Specific T-Cells.

Avital L. Amir, MD, Lloyd J.A. D’Orsogna, MD, Marleen M. van Loenen, MSC, Dave L. Roelen, PhD, Ilias I.N. Doxiadis, PhD, Frans H.J. Claas, PhD, J.H. Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2008) 112 (11): 3249.

https://doi.org/10.1182/blood.V112.11.3249.3249

Published: 2008

NARROW

Mutated NPM1 As Target for Immunotherapy of Acute Myeloid Leukemia

Induction of Antigen-Specific T-Cell Responses through Dendritic Cell Vaccination in AML: Results of a Phase I/II Trial and Ex Vivo Enhancement By Checkpoint Blockade

Inducible MyD88/CD40 (iMC) Enhances Proliferation and Survival of Tumor-Specific TCR-Modified T Cells and Improves Anti-Tumor Efficacy in Myeloma

Endogenous Immunoglobulin-Derived Neoepitopes Are Processed and Form a Sizeable Fraction of the HLA Class I Ligandome of Human Lymphoma Cells

T Cell Receptor Gene Therapy Targeting the Intracellular Transcription Factor Bob1 for the Treatment of Multiple Myeloma and Other B Cell Malignancies

Inducible MyD88/CD40 Enhances Proliferation and Survival of PRAME-Specific TCR-Engineered T Cells and Increases Anti-Tumor Effects in Myeloma

Functional Evaluation of T-Cells Generated from WT1-TCR Transduced Human Hematopoietic Stem Cells Using the OP9-DL1 Coculture System

T Cell Receptors Specific for the Intracellular Transcription Factor Bob1 Allow Efficient Targeting of Human B Cell Leukemia and Multiple Myeloma

High-Affinity CD20-Specific T-Cell Receptors Suitable for Adoptive Immunotherapy in the Treatment of CD20 low B-Cell Malignancies

Imprint Of Early CMV Reactivation On The Reconstituting T-Lymphocyte Compartment One and Two Year After Hematopoietic Stem Cell Transplantation

Occurrence of T Cells Specific for the Aspergillus Proteins Crf1 and Catalase1 in Patients Recovering From Invasive Aspergillosis

HLA-Peptidomics and the Identification of Clinical Relevant Minor Histocompatibility Antigens,

Identification of Multiple HLA Class II Epitopes of Aspergillus Fumigatus by Generation of CD4+ T Cell Clones Recognizing the A. Fumigatus proteins Crf1 and Catalase1

Extracellular Domains of CD8a and β Subunits Are Required and Sufficient for HLA Class I Restricted Helper Activity of TCR-Engineered CD4 + T Cells.

Allogeneic HLA-A2-Restricted WT1-Specific T Cells From Mismatched Donors Are Highly Reactive but Show Potentially Hazardous Promiscuity.

High Avidity PRAME Specific T Cells Derived From In Vivo HLA Mismatched Transplantation Setting Potentially Useful for Immunotherapeutic Strategies.

Optimization of the HA-1-Specific T Cell Receptor for Gene Therapy of Hematological Malignancies.

SNP-Based Genome-Wide Identification of Hematopoiesis-Restricted Minor Histocompatibility Antigens

Recombination of Endogenous TCR Chains with Retrovirally Introduced TCR Chains Can Result in Mixed T Cell Receptor Dimers Harbouring Harmful Alloreactivity

Alloreactivity of Virus Specific T-Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only